Orthopedics focuses on the musculoskeletal system. Learn about the diagnosis, treatment, and rehabilitation of bone, joint, ligament, and muscle conditions.
Send us all your questions or requests, and our expert team will assist you.
Treatment in Orthopedic Rheumatology is a dynamic interplay between medical suppression of the disease and surgical management of its consequences. The modern philosophy is “Treat to Target,” aiming for complete remission where no active inflammation exists. When structural damage has already occurred, the focus shifts to functional restoration through skilled orthopedic intervention.
Care plans are highly personalized, considering the patient’s specific disease subtype, lifestyle, and severity of joint destruction. The treatment timeline is lifelong, requiring constant adjustment to balance efficacy with safety.
Methotrexate is the anchor drug for most inflammatory arthritis patients. It works by interfering with the cellular reproduction of immune cells, effectively dampening the inflammatory fire. It is often the first line of defense to prevent joint damage.
Other traditional DMARDs include leflunomide, sulfasalazine, and hydroxychloroquine. These are often used in combination. Regular monitoring of liver function and blood counts is mandatory to ensure patient safety while on these medications.
Biologics have revolutionized care. These genetically engineered proteins target specific components of the immune system, such as Tumor Necrosis Factor (TNF) or Interleukin 6 (IL-6). They act like smart missiles, blocking the precise chemical signals that cause inflammation.
Examples include Adalimumab, Etanercept, and Tocilizumab. They are administered via injection or IV infusion. They are highly effective for patients who do not respond to traditional DMARDs, often inducing deep remission.
JAK inhibitors represent a newer class of “targeted synthetic” DMARDs. Unlike biologics, which are large proteins, these are small molecules taken orally. They work inside the cell to block the signaling pathways that trigger the nucleus to produce inflammatory proteins.
These offer the convenience of a pill with the potency of a biologic. They are a potent option for patients with difficult to treat disease or those who prefer to avoid injections.
Prednisone is a powerful anti inflammatory that works quickly to stop flares. However, it is a double edged sword. Long-term use destroys bone quality, thins the skin, and increases infection risk—all of which complicate orthopedic surgery.
The goal is to use the lowest effective dose for the shortest time possible. “Bridge therapy” uses steroids to control pain while waiting for DMARDs to kick in. Intra articular injections are preferred over systemic pills to limit side effects.
When medical management fails to clear inflammation from a specific joint, surgical synovectomy is indicated. The surgeon removes the hypertrophic, inflamed lining (pannus) of the joint. This eliminates the source of the destructive enzymes.
This can be done arthroscopically (minimally invasive) for knees and wrists, or openly for tendon sheaths. It preserves the joint/tendon by physically removing the tissue that is attacking it.
Rheumatic disease often leads to spontaneous tendon ruptures, particularly in the hand (e.g., extensor tendons). Direct repair is usually impossible because the remaining tendon is frayed and rotten.
Surgeons perform tendon transfers, taking a healthy, redundant tendon and rerouting it to power the broken function. This complex salvage procedure restores the ability to open the hand or extend the thumb.
Joint replacement is the definitive treatment for end stage destruction. In rheumatic patients, this surgery is more complex due to bone loss, ligament laxity, and deformity. Standard implants may not suffice.
Surgeons may use constrained liners or stemmed implants to provide extra stability. The timing is critical; the patient must be medically optimized to reduce infection risk, but surgery should not be delayed until the bone stock is wholly gone.
For certain joints, stability is more valuable than motion. The wrist, ankle, and hindfoot are common sites for fusion. By locking the damaged bones together, painful motion is eliminated, and a stable platform is created.
Fusion is a durable solution that never wears out. It allows patients to return to weight bearing activities without pain, albeit with altered mechanics that may require rocker bottom shoes or adaptive devices.
Rheumatoid arthritis can cause dangerous instability in the upper neck (C1, C2). If the vertebrae slip and compress the spinal cord, surgical stabilization is mandatory to prevent paralysis.
Surgeons perform a posterior cervical fusion, using screws and rods to lock the vertebrae in a safe position. This protects the neurologic structures while sacrificing some neck rotation.
The rheumatic hand presents with complex deformities like ulnar drift and swan neck fingers. Reconstruction often involves a combination of joint replacements (silicone implants) for the knuckles and fusions for the fingers.
The goal is to restore a functional grip and pinch. Aesthetic correction is secondary to functional restoration. Soft tissue balancing is as vital as the bone work to prevent the deformity from recurring.
Rheumatoid foot often involves severe bunions, hammertoes, and dislocation of the metatarsal heads, making walking painful. “The Rheumatoid Foot” feels like walking on marbles.
Reconstruction involves fusing the big toe and removing the heads of the lesser metatarsals (Hoffman procedure) to realign the foot. This allows the patient to fit into regular shoes and walk pain free.
Surgery in a rheumatic patient requires a precise schedule for holding and restarting medications. Stopping immunosuppressants reduces infection risk but increases the risk of a disease flare that could hamper rehab.
Guidelines (like those from the ACR) dictate exactly how many days before surgery to hold a biologic and when to restart it (typically after the wound is healed). Adherence to this schedule is vital for safety.
Patients with rheumatic disease are immunocompromised by both their condition and their medications. They are at higher risk for periprosthetic joint infection (PJI), a devastating complication.
Prevention involves rigorous skin preparation, antibiotic prophylaxis, and dental clearance. In some cases, antibiotic loaded bone cement is used during joint replacement to provide a local shield against bacteria.
Treating the bone is part of treating the joint. Patients are often placed on bisphosphonates (like Alendronate) or anabolic agents (like Teriparatide) to increase bone density.
Stronger bone provides a better anchor for surgical implants and prevents periprosthetic fractures. Management includes calcium and Vitamin D optimization as a baseline.
Pain in rheumatic patients is complex, often involving both inflammatory (joint) and neuropathic (nerve) components. Treatment goes beyond simple painkillers.
It includes the use of gabapentinoids for nerve pain, topical NSAIDs, and physical modalities like heat/cold therapy. Chronic opioid use is generally avoided due to poor long term efficacy and addiction risk.
Send us all your questions or requests, and our expert team will assist you.
The timing depends on the specific drug. Generally, surgery is scheduled at the end of a dosing cycle (e.g., if you inject weekly, surgery is done in the second week). You typically restart 14 days after surgery, provided the wound is healed and there is no infection.
In general, yes. While bone quality may be softer, modern implants are designed to last 15 to 20 years or more. Because rheumatic patients often have lower activity levels than osteoarthritis patients, the wear on the plastic bearing is usually less, potentially extending its life.
If you flare while your biologic is on hold, your doctors may use a short course of “stress dose” steroids to manage the inflammation without significantly increasing your infection risk. This keeps you comfortable until you can restart your main medication.
Surgery can significantly improve the alignment and function of the hand. Surgeons replace the knuckles with flexible hinges and rebalance the tendons. While the hand may not look “perfectly normal,” functionality and grip are vastly improved.
For many rheumatic patients, fusion is historically the gold standard because it is durable and stable. However, modern total ankle replacements are becoming an option for select patients with good bone stock who want to preserve motion. Your surgeon will evaluate your specific bone quality.
About 1 million people in the United States have psoriatic arthritis. This chronic condition affects both joints and skin. It causes pain, stiffness, and skin
Osteoarthritis is the most common arthritis type, affecting millions globally. It causes more than just joint pain—many experience Feeling Unwell with Osteoarthritis, which can impact
Psoriatic arthritis is a chronic condition that affects millions of people worldwide. It causes joint pain, swelling, and stiffness. If not treated, it can cause
Osteoarthritis (OA) is a degenerative joint disease that affects millions worldwide. It causes pain, swelling, and decreased mobility. A staggering number of people suffer from
Degenerative osteoarthritic disease is one of the most common joint conditions affecting millions of people worldwide. It causes pain, stiffness, and gradual damage to the
Your Comparison List (you must select at least 2 packages)
